Last update 07 Jun 2025

Recombinant interferon gamma(Xiamen Amoytop Biotech Co. Ltd.)

Overview

Basic Info

Drug Type
Interferons
Synonyms-
Target
IFNγ
Action
stimulants
Mechanism
IFNγ stimulants(Interferon gamma stimulants), Immunostimulants
Therapeutic Areas-
Active Indication-
Inactive Indication-
Originator Organization
Xiamen Amoytop Biotech Co. Ltd.Xiamen Amoytop Biotech Co. Ltd.
Active Organization-
Inactive Organization
BioGeneric Pharma SAE
License Organization-
Drug Highest PhasePendingClinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with Recombinant interferon gamma(Xiamen Amoytop Biotech Co. Ltd.)
Login to view more data
100 Translational Medicine associated with Recombinant interferon gamma(Xiamen Amoytop Biotech Co. Ltd.)
Login to view more data
100 Patents (Medical) associated with Recombinant interferon gamma(Xiamen Amoytop Biotech Co. Ltd.)
Login to view more data
122
Literatures (Medical) associated with Recombinant interferon gamma(Xiamen Amoytop Biotech Co. Ltd.)
27 Jan 2025Infectious disorders drug targets
A Clinical Multicenter Trial of Recombinant Human Interferon Gamma in Tuberculosis (GAM2022) Experience with the Use of Human Recombinant Interferon Gamma in TB Practice
11 Mar 2023Voprosy virusologii
[In vitro activity of human recombinant interferon gamma against SARS-CoV-2 virus].
01 Jun 2011Journal of neurology, neurosurgery, and psychiatry
Intracranial aneurysms associated with hyperimmunoglobulinaemia E (Job) syndrome: report of two cases
100 Deals associated with Recombinant interferon gamma(Xiamen Amoytop Biotech Co. Ltd.)
Login to view more data

External Link

KEGGWikiATCDrug Bank
--
L03AB03
-

R&D Status

Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free